Silver Book Fact

Fact image

Costs That Can Be Avoided, 2003-2023

DeVol, Ross, Armen Bedroussian, Anita Charuworn, Anusuya Chatterjee, In Kyu Kim, Soojung Kim, and Kevin Klowden. An Unhealthy America: The economic burden of chronic disease. The Milken Institute; October 2007. http://www.milkeninstitute.org/publications/publications.taf?function=detail&ID=38801018&cat=ResRep

Reference

Title
An Unhealthy America: The economic burden of chronic disease
Publisher
The Milken Institute
Publication Date
October 2007
Authors
DeVol, Ross, Armen Bedroussian, Anita Charuworn, Anusuya Chatterjee, In Kyu Kim, Soojung Kim, and Kevin Klowden
URL
Read Full Resource

Categories

  • Innovative Medical Research
  • Future Value

Related Facts

  • In an optimistic scenario, more effective prevention and management of disease could save $218 billion in treatment expenditures annually in 2023.  
  • Private health insurance benefit spending is predicted to slow from a peak of 9.5% in 2001 to 4.7% in 2006, partially because of Medicare Part D.  
  • According to the Pharmaceutical Research and Manufacturers of America, medical research could result in $149 billion in savings for government programs by 2025.  
  • Spending $11,000 on general medical care adds an average of 1 year of life. Spending only $1,345 on pharmaceutical research and development yields the same return.  
  • Using Newer Medicines Results in Savings of $111 per Treated Condition